Knocking down ACTL6A expression with shACTL6A significantly reduced tumor growth, and NAC treatment (intraperitoneal (i.p.)injection, 200 mg/kg/day) significantly reversed this effect (Fig. 2k–n). Here, ACTL6A is linked to neoplasm.